Sativex Eased MS Spasticity as an Add-on Therapy

Sativex Eased MS Spasticity as an Add-on Therapy

298719

Sativex Eased MS Spasticity as an Add-on Therapy

Sativex (nabiximols), an oral spray that contains cannabis extracts, was found effective as an add-on therapy for easing spasticity in adult multiple sclerosis (MS) patients who failed to respond to other anti-spastic treatments, a real-world study from Belgium reports. Overall, about 74% patients reported easing of spasticity — muscle stiffness or spasms —after 12 weeks of treatment, defined as a 30%-or-greater reduction in spasticity scores. The study, “Sativex (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity:…

You must be logged in to read/download the full post.